about
Converse regulatory functions of estrogen receptor-alpha and -beta subtypes expressed in hypothalamic gonadotropin-releasing hormone neuronsStevens-johnson syndrome associated with drugs and vaccines in children: a case-control studyAn agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion.Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndromeEffects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndromeLong-acting beta-agonists and their association with inhaled corticosteroids in COPD.Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia.Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases.Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy.Heme oxygenase-derived carbon monoxide modulates gonadotropin-releasing hormone release in immortalized hypothalamic neurons.Heme oxygenase expression and activity in immortalized hypothalamic neurons GT1-7.Interleukin-18 displays effects opposite to those of interleukin-1 in the regulation of neuroendocrine stress axis.Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome.Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis.Intravascular tumor necrosis factor α blockade reverses endothelial dysfunction in rheumatoid arthritisFurther considerations on adverse reactions to radiopharmaceuticalsWithin-day and between-day repeatability of measurements with an electronic nose in patients with COPDTwenty-four-hour blood pressure monitoring after a single dose of sustained-release verapamilEffect of sustained-release verapamil therapy on the blood pressure at rest and on the pressor response to isometric exertion in hypertensive patientsEffects of benazepril on stress testing blood pressure in essential hypertensionPresynaptic A2-adrenoceptors and neuropeptide Y Y2 receptors inhibit [3H]noradrenaline release from rat hypothalamic synaptosomes via different mechanismsMediation of cyclic AMP signaling by the first intracellular loop of the gonadotropin-releasing hormone receptorEssential role of G protein-gated inwardly rectifying potassium channels in gonadotropin-induced regulation of GnRH neuronal firing and pulsatile neurosecretionTumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's diseasePlasma levels of cell adhesion molecules during hyperinsulinemia and modulation of vasoactive mediatorsGhrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndromeCoexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans
P50
Q24658091-67AEDCB5-7AF2-4632-BDB5-2720F819DE02Q28534684-BF82920B-A6C0-4637-9963-CAC496490372Q34809328-8D7C1AC9-81D0-4CD6-997C-CABC62635F56Q36309209-B2D206E8-B319-4E77-A2C3-1CCAAC1D80E4Q36629691-8D912EB1-2288-4508-8963-2F213BC464F3Q38081484-4AE6E352-1E1E-4A96-BF73-ABCFCB6D5F0AQ38172639-473CBFB0-BA8B-45EF-ACB3-F46268F3D4A3Q38198321-91DE587D-9DF3-414F-B1F1-754558FD8FADQ39170352-BE096968-4928-447D-8D42-0FEBB4B7EE70Q39748699-9DB457B0-24C1-43E5-B3C3-6FF317BBBB82Q39950152-F04A7F7D-A507-4385-AFB8-89EA66E01041Q42474304-0952105D-F7FF-4196-BD0A-30CC6788674BQ43685123-B568ABB4-905B-412B-996C-E26E7A565E26Q45990920-39564467-F60D-44BB-9729-600E1AEEF6C2Q57753828-8B73D908-E60B-4D93-8F02-D8AAE4B27DE6Q58005462-5577345A-ACB9-4D9D-A7FA-0063AECE9560Q61951612-8C7A6A8B-60B7-406F-88C3-27D9776796C3Q67270649-156AD21C-B0FE-4F51-AE2D-EE4B56E8E61EQ67929154-EB39CBCF-A247-4030-BDA4-0907D5FEA443Q72245723-66DB66D4-A362-4FB9-A26C-49AFA07D048EQ72319900-961B0EA0-33C9-433D-AE52-4C5401481D0DQ77332882-5B786357-6254-40C1-AFE7-9E385B887F54Q79850909-8616B51C-C2DB-4628-8199-1EDA452AD387Q80347494-D2B3670E-A383-4E48-A4BC-FD6C473745C3Q81327983-22296C8C-F5FB-4906-96C7-BC5D5C7A0E44Q84592589-9B63C618-D507-46C3-B0C0-AFBC22C93FF7Q84763598-9CA03AAE-ED68-4616-8D67-96F805724B95
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-4197-0914
@en
name
Nadia Mores
@ast
Nadia Mores
@en
Nadia Mores
@es
Nadia Mores
@nl
type
label
Nadia Mores
@ast
Nadia Mores
@en
Nadia Mores
@es
Nadia Mores
@nl
prefLabel
Nadia Mores
@ast
Nadia Mores
@en
Nadia Mores
@es
Nadia Mores
@nl
P106
P1153
55941873300
P21
P31
P496
0000-0002-4197-0914